Oruka Therapeutics, Inc. (ORKA)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $7.15B
Last updated: Nov 17, 2026 at 11:06 AM ET
Oruka Therapeutics, Inc. (ORKA) Earnings: Report Dates and Results
Oruka Therapeutics (ORKA) is expected to report earnings on Mar 10, 2027. In the quarter ended Sep 30, 2026, Oruka Therapeutics reported EPS of -$0.63, above the -$0.68 estimate. It beat the EPS estimate in 4 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
ORKA has an expected report date of Mar 10, 2027.
Earnings History
Of the 22 quarters below that had an estimate, ORKA beat 16 and missed 6. The widest gap in the table came in the quarter ended Sep 30, 2018, when EPS landed 942.11% below the estimate.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported |
|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | -$0.63 | -$0.68 | -$0.79 - -$0.41 | +7.35% | Beat | N/A | 9 | 1 up, 7 down | Nov 9, 2026 |
| Jun 30, 2026 | -$0.55 | -$0.49 | -$0.67 - -$0.41 | -12.24% | Miss | N/A | 9 | 7 up, 2 down | Aug 10, 2026 |
| Mar 31, 2026 | -$0.48 | -$0.54 | -$0.65 - -$0.47 | +11.11% | Beat | N/A | 8 | 0 up, 2 down | May 13, 2026 |
| Dec 31, 2025 | -$0.45 | -$0.62 | -$0.85 - -$0.47 | +26.90% | Beat | N/A | 8 | 1 up, 1 down | Mar 12, 2026 |
| Sep 30, 2025 | -$0.55 | -$0.52 | -$0.60 - -$0.40 | -5.77% | Miss | N/A | 5 | 1 up, 0 down | Nov 12, 2025 |
| Jun 30, 2025 | -$0.46 | -$0.43 | -$0.52 - -$0.31 | -6.98% | Miss | N/A | 4 | 1 up, 2 down | Aug 11, 2025 |
| Mar 31, 2025 | -$0.40 | -$0.44 | N/A | +9.09% | Beat | N/A | N/A | N/A | May 14, 2025 |
| Dec 31, 2024 | -$0.54 | -$0.41 | -$0.46 - -$0.20 | -31.71% | Miss | N/A | 3 | 1 up, 0 down | Mar 6, 2025 |
| Sep 30, 2024 | -$1.46 | -$0.32 | -$0.45 - -$0.20 | -356.25% | Miss | N/A | 4 | 1 up, 0 down | Nov 13, 2024 |
| Jun 30, 2024 | -$2.22 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Aug 27, 2024 |
| Mar 31, 2024 | -$0.14 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Apr 25, 2024 |
| Dec 31, 2023 | -$0.90 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Feb 1, 2024 |
| Sep 30, 2023 | -$1.19 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Nov 7, 2023 |
| Jun 30, 2023 | -$1.23 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Jul 21, 2023 |
| Mar 31, 2023 | -$0.09 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Jun 29, 2023 |
| Dec 31, 2022 | -$0.08 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Mar 30, 2023 |
| Sep 30, 2022 | -$0.16 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Oct 28, 2022 |
| Jun 30, 2022 | -$0.22 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Aug 2, 2022 |
| Mar 31, 2022 | -$0.55 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Jun 29, 2022 |
| Dec 31, 2021 | -$0.55 | -$2.24 | N/A | +75.45% | Beat | N/A | N/A | N/A | Mar 30, 2022 |
| Sep 30, 2021 | -$0.33 | -$2.30 | N/A | +85.65% | Beat | N/A | N/A | N/A | Nov 2, 2021 |
| Jun 30, 2021 | -$0.34 | -$2.37 | N/A | +85.65% | Beat | N/A | N/A | N/A | Aug 4, 2021 |
| Mar 31, 2021 | -$0.33 | -$1.87 | N/A | +82.35% | Beat | N/A | N/A | N/A | Jun 29, 2021 |
| Dec 31, 2020 | -$0.55 | -$2.44 | N/A | +77.46% | Beat | N/A | N/A | N/A | Mar 30, 2021 |
| Sep 30, 2020 | -$0.33 | -$2.51 | N/A | +86.85% | Beat | N/A | N/A | N/A | Nov 2, 2020 |
| Jun 30, 2020 | -$0.73 | -$2.58 | N/A | +71.71% | Beat | N/A | N/A | N/A | Aug 5, 2020 |
| Mar 31, 2020 | -$0.83 | -$2.04 | N/A | +59.31% | Beat | N/A | N/A | N/A | Jun 29, 2020 |
| Dec 31, 2019 | -$0.39 | -$0.99 | N/A | +60.61% | Beat | N/A | N/A | N/A | Mar 30, 2020 |
| Sep 30, 2019 | -$0.76 | -$1.30 | N/A | +41.54% | Beat | N/A | N/A | N/A | Nov 6, 2019 |
| Jun 30, 2019 | -$1.14 | -$1.86 | N/A | +38.71% | Beat | N/A | N/A | N/A | Aug 1, 2019 |
| Mar 31, 2019 | -$1.86 | -$1.98 | N/A | +6.06% | Beat | N/A | N/A | N/A | Jun 29, 2019 |
| Dec 31, 2018 | -$1.98 | -$0.14 | N/A | N/A | N/A | N/A | N/A | N/A | Mar 30, 2019 |
| Sep 30, 2018 | -$1.98 | -$0.19 | N/A | -942.11% | Miss | N/A | N/A | N/A | Nov 14, 2018 |
| Jun 30, 2018 | -$2.70 | -$0.22 | N/A | N/A | N/A | N/A | N/A | N/A | Aug 9, 2018 |
| Mar 31, 2018 | -$43.37 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Jun 29, 2018 |
| Dec 31, 2017 | -$76.99 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Mar 30, 2018 |
| Sep 30, 2017 | -$83.24 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Nov 10, 2017 |
| Jun 30, 2017 | -$127.91 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Aug 15, 2017 |
| Mar 31, 2017 | -$103.03 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Jun 29, 2017 |
| Dec 31, 2016 | -$100.93 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Mar 30, 2017 |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was -$1.86, after -$4.36 the year before. It was -$391.70 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | -$1.86 | N/A |
| Dec 31, 2024 | -$4.36 | N/A |
| Dec 31, 2023 | -$3.41 | N/A |
| Dec 31, 2022 | -$1.01 | N/A |
| Dec 31, 2021 | -$1.55 | N/A |
| Dec 31, 2020 | -$2.44 | N/A |
| Dec 31, 2019 | -$4.15 | N/A |
| Dec 31, 2018 | -$50.03 | N/A |
| Dec 31, 2017 | -$391.18 | N/A |
| Dec 31, 2016 | -$391.70 | N/A |
Frequently Asked Questions About ORKA
When is Oruka Therapeutics's next earnings date?
Oruka Therapeutics's next earnings report is expected for Mar 10, 2027.
Did ORKA beat earnings estimates last quarter?
Yes. Oruka Therapeutics reported EPS of -$0.63 for the quarter ended Sep 30, 2026, above the -$0.68 estimate, a 7.35% surprise.
What EPS do analysts expect from ORKA next quarter?
The consensus EPS estimate for Oruka Therapeutics for the quarter ending Dec 31, 2026 is -$0.69 from 14 analysts, with estimates from -$0.98 to -$0.38.
How often does ORKA beat earnings estimates?
Oruka Therapeutics beat the EPS estimate in 4 of the last 8 quarters, with an average surprise of -0.28%.